REFERENCES
- Biancardi AL, Moraes HV. Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2019;27(4):521–523.
- Brandão-de-Resende C, Cunha LHM, Oliveira SL, et al. Characterization of retinopathy among patients with yellow fever during 2 outbreaks in southeastern Brazil. JAMA Ophthalmol. 2019;In press. (publication scheduled to June 20th 2019). doi:10.1001/jamaophthalmol.2019.1956.
- Seligman SJ, Casanova JL. Yellow fever vaccine: worthy friend or stealthy foe? Expert Rev Vaccines. 2016;15:681–691. doi:10.1080/14760584.2016.1180250.
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652. doi:10.1016/s0002-9394(01)00925-4.
- Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29. doi:10.1186/s13023-016-0412-4.
- Yoshino N, Kawamura A, Ishii A, et al. Vogt-Koyanagi-Harada disease associated with influenza A virus infection. Internal Medicine. 2018;57:1661–1665. doi:10.2169/internalmedicine.9819-17.